---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-24-000117"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:43:43.026826+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Evolent Health amends credit agreement adding $250M in new debt facilities

## Summary
- Increased existing ABL revolver by $50M (with $25M funded); new delayed draw term loans of $125M and $75M.
- Interest rates: ABL at SOFR + 4.00% or base + 3.00%; term loans at SOFR + 5.50% or base + 4.50%.
- Maturity is earliest of 5 years from Dec 6, 2024, or 180 days before 2029 convertible notes maturity.
- Borrowing under term loans requires total secured leverage ratio ≤ 2.00:1.00.
- Upfront fees: 1% on ABL commitment; 2% (reducible to 1%) on term loan amounts funded.

## SEC filing metadata
- accession: 0001628908-24-000117
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/0001628908-24-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/evh-20241206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-24-000117
- JSON: https://secwatch.observer/filing/0001628908-24-000117.json
- Plain text: https://secwatch.observer/filing/0001628908-24-000117.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.